Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 359

1.

Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies.

Motohashi N, Shimizu-Motohashi Y, Roberts TC, Aoki Y.

Cells. 2019 Sep 11;8(9). pii: E1066. doi: 10.3390/cells8091066. Review.

2.

Restoring Dystrophin Expression in Duchenne Muscular Dystrophy: Current Status of Therapeutic Approaches.

Shimizu-Motohashi Y, Komaki H, Motohashi N, Takeda S, Yokota T, Aoki Y.

J Pers Med. 2019 Jan 7;9(1). pii: E1. doi: 10.3390/jpm9010001. Review.

3.

An inducible knockout of Dicer in adult mice does not affect endurance exercise-induced muscle adaptation.

Oikawa S, Lee M, Motohashi N, Maeda S, Akimoto T.

Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C285-C292. doi: 10.1152/ajpcell.00278.2018. Epub 2018 Dec 12.

PMID:
30540495
4.

Tbx1 regulates inherited metabolic and myogenic abilities of progenitor cells derived from slow- and fast-type muscle.

Motohashi N, Uezumi A, Asakura A, Ikemoto-Uezumi M, Mori S, Mizunoe Y, Takashima R, Miyagoe-Suzuki Y, Takeda S, Shigemoto K.

Cell Death Differ. 2019 Jun;26(6):1024-1036. doi: 10.1038/s41418-018-0186-4. Epub 2018 Aug 28.

PMID:
30154444
5.

Short- and long-term evaluation of cognitive functions after electroconvulsive therapy in a Japanese population.

Takagi S, Takeuchi T, Yamamoto N, Fujita M, Furuta K, Ishikawa H, Motohashi N, Nishikawa T.

Psychiatry Clin Neurosci. 2018 Feb;72(2):95-102. doi: 10.1111/pcn.12614. Epub 2017 Nov 29.

6.

Immunization of mice with LRP4 induces myasthenia similar to MuSK-associated myasthenia gravis.

Mori S, Motohashi N, Takashima R, Kishi M, Nishimune H, Shigemoto K.

Exp Neurol. 2017 Nov;297:158-167. doi: 10.1016/j.expneurol.2017.08.006. Epub 2017 Aug 18.

7.

Plasma Amyloid-β and Alzheimer's Disease-Related Changes in Late-Life Depression.

Yamazaki C, Tamaoki T, Nunomura A, Tamai K, Yasuda K, Motohashi N.

J Alzheimers Dis. 2017;58(2):349-354. doi: 10.3233/JAD-170111.

PMID:
28453490
8.

[Animal models of myasthenia gravis].

Shigemoto K, Takashima R, Motohashi N, Mori S.

Nihon Rinsho. 2015 Sep;73 Suppl 7:97-104. Japanese. No abstract available.

PMID:
26480686
9.

Stem Cell Differentiation and Therapeutic Use.

Alexander MS, Casar JC, Motohashi N.

Stem Cells Int. 2015;2015:308128. doi: 10.1155/2015/308128. Epub 2015 Aug 4. No abstract available.

10.

Immunohistochemical characterization of CD33 expression on microglia in Nasu-Hakola disease brains.

Satoh J, Kino Y, Motohashi N, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.

Neuropathology. 2015 Dec;35(6):529-37. doi: 10.1111/neup.12222. Epub 2015 Jun 18.

PMID:
26087043
11.
12.

Autistic-like traits in adult patients with mood disorders and schizophrenia.

Matsuo J, Kamio Y, Takahashi H, Ota M, Teraishi T, Hori H, Nagashima A, Takei R, Higuchi T, Motohashi N, Kunugi H.

PLoS One. 2015 Apr 2;10(4):e0122711. doi: 10.1371/journal.pone.0122711. eCollection 2015.

13.

Pregnancy-induced amelioration of muscular dystrophy phenotype in mdx mice via muscle membrane stabilization effect of glucocorticoid.

Shimizu-Motohashi Y, Asakura Y, Motohashi N, Belur NR, Baumrucker MG, Asakura A.

PLoS One. 2015 Mar 16;10(3):e0120325. doi: 10.1371/journal.pone.0120325. eCollection 2015.

14.

[Role of oxidative stress in the pathophysiology of neuropsychiatric disorders].

Nunomura A, Tamaoki T, Motohashi N.

Seishin Shinkeigaku Zasshi. 2014;116(10):842-58. Japanese.

PMID:
25672211
15.

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.

Ogawa S, Hattori K, Sasayama D, Yokota Y, Matsumura R, Matsuo J, Ota M, Hori H, Teraishi T, Yoshida S, Noda T, Ohashi Y, Sato H, Higuchi T, Motohashi N, Kunugi H.

Sci Rep. 2015 Jan 15;5:7796. doi: 10.1038/srep07796.

16.

Muscle satellite cell heterogeneity and self-renewal.

Motohashi N, Asakura A.

Front Cell Dev Biol. 2014 Jan 30;2:1. doi: 10.3389/fcell.2014.00001. eCollection 2014. Review.

17.

Plasma L-tryptophan concentration in major depressive disorder: new data and meta-analysis.

Ogawa S, Fujii T, Koga N, Hori H, Teraishi T, Hattori K, Noda T, Higuchi T, Motohashi N, Kunugi H.

J Clin Psychiatry. 2014 Sep;75(9):e906-15. doi: 10.4088/JCP.13r08908.

PMID:
25295433
18.

Seizure threshold and the half-age method in bilateral electroconvulsive therapy in Japanese patients.

Yasuda K, Kobayashi K, Yamaguchi M, Tanaka K, Fujii T, Kitahara Y, Tamaoki T, Matsushita Y, Nunomura A, Motohashi N.

Psychiatry Clin Neurosci. 2015 Jan;69(1):49-54. doi: 10.1111/pcn.12225. Epub 2014 Sep 12.

19.

LC3, an autophagosome marker, is expressed on oligodendrocytes in Nasu-Hakola disease brains.

Satoh J, Motohashi N, Kino Y, Ishida T, Yagishita S, Jinnai K, Arai N, Nakamagoe K, Tamaoka A, Saito Y, Arima K.

Orphanet J Rare Dis. 2014 May 1;9:68. doi: 10.1186/1750-1172-9-68.

20.

MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms.

Alexander MS, Casar JC, Motohashi N, Vieira NM, Eisenberg I, Marshall JL, Gasperini MJ, Lek A, Myers JA, Estrella EA, Kang PB, Shapiro F, Rahimov F, Kawahara G, Widrick JJ, Kunkel LM.

J Clin Invest. 2014 Jun;124(6):2651-67. doi: 10.1172/JCI73579. Epub 2014 May 1.

21.

Isolation, culture, and transplantation of muscle satellite cells.

Motohashi N, Asakura Y, Asakura A.

J Vis Exp. 2014 Apr 8;(86). doi: 10.3791/50846.

22.

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia.

Hirano J, Watanabe K, Suzuki T, Uchida H, Den R, Kishimoto T, Nagasawa T, Tomita Y, Hara K, Ochi H, Kobayashi Y, Ishii M, Fujita A, Kanai Y, Goto M, Hayashi H, Inamura K, Ooshima F, Sumida M, Ozawa T, Sekigawa K, Nagaoka M, Yoshimura K, Konishi M, Inagaki A, Saito T, Motohashi N, Mimura M, Okubo Y, Kato M.

Neuropsychiatr Dis Treat. 2013;9:1553-64. doi: 10.2147/NDT.S46108. Epub 2013 Oct 11.

23.

[Recommendations for ECT Practice, Second Edition].

Motohashi N, Awata S, Isse K, Ueda S, Okubo Y, Okumura M, Kashima H, Kawasaki H, Sameshima T, Sawa Y, Takebayashi M, Hatta K, Wakejima T, Wada K, Yamaguchi N, Yoneda H.

Seishin Shinkeigaku Zasshi. 2013;115(6):586-600. Review. Japanese. No abstract available.

PMID:
23944116
24.

Mood and cognitive function following repeated transcranial direct current stimulation in healthy volunteers: a preliminary report.

Motohashi N, Yamaguchi M, Fujii T, Kitahara Y.

Neurosci Res. 2013 Sep-Oct;77(1-2):64-9. doi: 10.1016/j.neures.2013.06.001. Epub 2013 Jun 25.

PMID:
23811267
25.

MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation.

Alexander MS, Kawahara G, Motohashi N, Casar JC, Eisenberg I, Myers JA, Gasperini MJ, Estrella EA, Kho AT, Mitsuhashi S, Shapiro F, Kang PB, Kunkel LM.

Cell Death Differ. 2013 Sep;20(9):1194-208. doi: 10.1038/cdd.2013.62. Epub 2013 Jun 14.

26.

Regulation of IRS1/Akt insulin signaling by microRNA-128a during myogenesis.

Motohashi N, Alexander MS, Shimizu-Motohashi Y, Myers JA, Kawahara G, Kunkel LM.

J Cell Sci. 2013 Jun 15;126(Pt 12):2678-91. doi: 10.1242/jcs.119966. Epub 2013 Apr 19.

27.

[Will electroconvulsive therapy disappear in the near future?].

Motohashi N.

Seishin Shinkeigaku Zasshi. 2012;114(10):1208-15. Review. Japanese.

PMID:
23234202
28.

Molecular Regulation of Muscle Satellite Cell Self-Renewal.

Motohashi N, Asakura A.

J Stem Cell Res Ther. 2012 Nov;Suppl 11. pii: e002. No abstract available.

29.

Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftment.

Lawlor MW, Alexander MS, Viola MG, Meng H, Joubert R, Gupta V, Motohashi N, Manfready RA, Hsu CP, Huang P, Buj-Bello A, Kunkel LM, Beggs AH, Gussoni E.

Am J Pathol. 2012 Sep;181(3):961-8. doi: 10.1016/j.ajpath.2012.05.016. Epub 2012 Jul 27.

30.

Identification of a novel microRNA that regulates the proliferation and differentiation in muscle side population cells.

Motohashi N, Alexander MS, Casar JC, Kunkel LM.

Stem Cells Dev. 2012 Nov 1;21(16):3031-43. doi: 10.1089/scd.2011.0721. Epub 2012 Jun 12.

31.

Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.

Varga ZG, Armada A, Cerca P, Amaral L, Mior Ahmad Subki MA, Savka MA, Szegedi E, Kawase M, Motohashi N, Molnár J.

In Vivo. 2012 Mar-Apr;26(2):277-85.

PMID:
22351670
32.

The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons.

Nunomura A, Tamaoki T, Motohashi N, Nakamura M, McKeel DW Jr, Tabaton M, Lee HG, Smith MA, Perry G, Zhu X.

J Neuropathol Exp Neurol. 2012 Mar;71(3):233-41. doi: 10.1097/NEN.0b013e318248e614.

33.

Reprogramming efficiency and quality of induced Pluripotent Stem Cells (iPSCs) generated from muscle-derived fibroblasts of mdx mice at different ages.

Wang B, Miyagoe-Suzuki Y, Yada E, Ito N, Nishiyama T, Nakamura M, Ono Y, Motohashi N, Segawa M, Masuda S, Takeda S.

PLoS Curr. 2011 Oct 27;3:RRN1274.

34.

Hesr1 and Hesr3 are essential to generate undifferentiated quiescent satellite cells and to maintain satellite cell numbers.

Fukada S, Yamaguchi M, Kokubo H, Ogawa R, Uezumi A, Yoneda T, Matev MM, Motohashi N, Ito T, Zolkiewska A, Johnson RL, Saga Y, Miyagoe-Suzuki Y, Tsujikawa K, Takeda S, Yamamoto H.

Development. 2011 Nov;138(21):4609-19. doi: 10.1242/dev.067165.

35.

Differences in cerebral blood flow between missed and generalized seizures with electroconvulsive therapy: a positron emission tomographic study.

Takano H, Motohashi N, Uema T, Ogawa K, Ohnishi T, Nishikawa M, Matsuda H.

Epilepsy Res. 2011 Nov;97(1-2):225-8. doi: 10.1016/j.eplepsyres.2011.08.007. Epub 2011 Sep 13.

PMID:
21917425
36.

Regulation of DMD pathology by an ankyrin-encoded miRNA.

Alexander MS, Casar JC, Motohashi N, Myers JA, Eisenberg I, Gonzalez RT, Estrella EA, Kang PB, Kawahara G, Kunkel LM.

Skelet Muscle. 2011 Aug 8;1:27. doi: 10.1186/2044-5040-1-27.

37.

Plastid-to-nucleus retrograde signals are essential for the expression of nuclear starch biosynthesis genes during amyloplast differentiation in tobacco BY-2 cultured cells.

Enami K, Ozawa T, Motohashi N, Nakamura M, Tanaka K, Hanaoka M.

Plant Physiol. 2011 Sep;157(1):518-30. doi: 10.1104/pp.111.178897. Epub 2011 Jul 19.

38.
39.

Chronic repetitive transcranial magnetic stimulation failed to change dopamine synthesis rate: preliminary L-[β-11C]DOPA positron emission tomography study in patients with depression.

Kuroda Y, Motohashi N, Ito H, Ito S, Takano A, Takahashi H, Nishikawa T, Suhara T.

Psychiatry Clin Neurosci. 2010 Dec;64(6):659-62.

40.

Six family genes control the proliferation and differentiation of muscle satellite cells.

Yajima H, Motohashi N, Ono Y, Sato S, Ikeda K, Masuda S, Yada E, Kanesaki H, Miyagoe-Suzuki Y, Takeda S, Kawakami K.

Exp Cell Res. 2010 Oct 15;316(17):2932-44. doi: 10.1016/j.yexcr.2010.08.001. Epub 2010 Aug 6.

PMID:
20696153
41.
42.
43.

Emphysema on imaging is associated with quality of life in elderly patients with chronic obstructive pulmonary disease.

Motohashi N, Kimura K, Ishii T, Wakabayashi R, Kurosaki H, Motegi T, Yamada K, Jones RC, Gemma A, Kida K.

Geriatr Gerontol Int. 2010 Jan;10(1):17-24. doi: 10.1111/j.1447-0594.2009.00549.x.

PMID:
20102378
44.

Intraneuronal amyloid beta accumulation and oxidative damage to nucleic acids in Alzheimer disease.

Nunomura A, Tamaoki T, Tanaka K, Motohashi N, Nakamura M, Hayashi T, Yamaguchi H, Shimohama S, Lee HG, Zhu X, Smith MA, Perry G.

Neurobiol Dis. 2010 Mar;37(3):731-7. doi: 10.1016/j.nbd.2009.12.012. Epub 2009 Dec 23.

45.

A case of ring chromosome 18 syndrome treated with a combined orthodontic-prosthodontic approach.

Ono T, Okuma M, Hamada T, Motohashi N, Moriyama K.

Cleft Palate Craniofac J. 2010 Mar;47(2):201-10. doi: 10.1597/08-262.1.

PMID:
19860520
46.

Tumor-specific cytotoxicity and type of cell death induced by benzo[b]cyclohept[e][1,4]oxazine and 2-aminotropone derivatives.

Narita T, Suga A, Kobayashi M, Hashimoto K, Sakagami H, Motohashi N, Kurihara T, Wakabayashi H.

Anticancer Res. 2009 Apr;29(4):1123-30.

47.

Tumor-specific cytotoxicity and type of cell death induced by naphtho[2,3-b]furan-4,9-diones and related compounds in human tumor cell lines: relationship to electronic structure.

Takano A, Hashimoto K, Ogawa M, Koyanagi J, Kurihara T, Wakabayashi H, Kikuchi H, Nakamura Y, Motohashi N, Sakagami H, Yamamoto K, Tanaka A.

Anticancer Res. 2009 Jan;29(1):455-64.

48.

New high-throughput screening assay to reveal similarities and differences in inhibitory sensitivities of multidrug ATP-binding cassette transporters.

Kolaczkowski M, Kolaczkowska A, Motohashi N, Michalak K.

Antimicrob Agents Chemother. 2009 Apr;53(4):1516-27. doi: 10.1128/AAC.00956-08. Epub 2009 Feb 2.

49.

Generation of transplantable, functional satellite-like cells from mouse embryonic stem cells.

Chang H, Yoshimoto M, Umeda K, Iwasa T, Mizuno Y, Fukada S, Yamamoto H, Motohashi N, Miyagoe-Suzuki Y, Takeda S, Heike T, Nakahata T.

FASEB J. 2009 Jun;23(6):1907-19. doi: 10.1096/fj.08-123661. Epub 2009 Jan 23.

PMID:
19168704
50.

Extent of emphysema on HRCT affects loss of fat-free mass and fat mass in COPD.

Kurosaki H, Ishii T, Motohashi N, Motegi T, Yamada K, Kudoh S, Jones RC, Kida K.

Intern Med. 2009;48(1):41-8. Epub 2009 Jan 1.

Supplemental Content

Loading ...
Support Center